BAYER AG-REG (BAYN.DE) Fundamental Analysis & Valuation

FRA:BAYN • DE000BAY0017

Current stock price

41.1 EUR
+0.41 (+1.01%)
Last:

This BAYN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BAYN.DE Profitability Analysis

1.1 Basic Checks

  • In the past year BAYN was profitable.
  • In the past year BAYN had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: BAYN reported negative net income in multiple years.
  • Each year in the past 5 years BAYN had a positive operating cash flow.
BAYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBAYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B -10B

1.2 Ratios

  • BAYN's Return On Assets of -3.46% is on the low side compared to the rest of the industry. BAYN is outperformed by 64.71% of its industry peers.
  • Looking at the Return On Equity, with a value of -13.95%, BAYN is doing worse than 64.71% of the companies in the same industry.
Industry RankSector Rank
ROA -3.46%
ROE -13.95%
ROIC N/A
ROA(3y)-2.76%
ROA(5y)-0.83%
ROE(3y)-10.29%
ROE(5y)-3.43%
ROIC(3y)N/A
ROIC(5y)N/A
BAYN.DE Yearly ROA, ROE, ROICBAYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • BAYN's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 58.76%, BAYN is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
  • BAYN's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for BAYN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.76%
OM growth 3Y-5.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y1.79%
BAYN.DE Yearly Profit, Operating, Gross MarginsBAYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. BAYN.DE Health Analysis

2.1 Basic Checks

  • BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BAYN remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, BAYN has about the same amount of shares outstanding.
  • BAYN has a better debt/assets ratio than last year.
BAYN.DE Yearly Shares OutstandingBAYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
BAYN.DE Yearly Total Debt VS Total AssetsBAYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • Based on the Altman-Z score of 0.78, we must say that BAYN is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.78, BAYN is not doing good in the industry: 78.43% of the companies in the same industry are doing better.
  • BAYN has a debt to FCF ratio of 10.93. This is a negative value and a sign of low solvency as BAYN would need 10.93 years to pay back of all of its debts.
  • BAYN's Debt to FCF ratio of 10.93 is on the low side compared to the rest of the industry. BAYN is outperformed by 70.59% of its industry peers.
  • A Debt/Equity ratio of 1.23 is on the high side and indicates that BAYN has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.23, BAYN is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF 10.93
Altman-Z 0.78
ROIC/WACCN/A
WACC6.64%
BAYN.DE Yearly LT Debt VS Equity VS FCFBAYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

  • BAYN has a Current Ratio of 1.01. This is a normal value and indicates that BAYN is financially healthy and should not expect problems in meeting its short term obligations.
  • BAYN has a worse Current ratio (1.01) than 72.55% of its industry peers.
  • BAYN has a Quick Ratio of 1.01. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of BAYN (0.63) is worse than 80.39% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.63
BAYN.DE Yearly Current Assets VS Current LiabilitesBAYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. BAYN.DE Growth Analysis

3.1 Past

  • The earnings per share for BAYN have decreased by -2.77% in the last year.
  • Measured over the past years, BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.13% on average per year.
  • BAYN shows a decrease in Revenue. In the last year, the revenue decreased by -2.21%.
  • The Revenue has been growing slightly by 1.94% on average over the past years.
EPS 1Y (TTM)-2.77%
EPS 3Y-14.8%
EPS 5Y-5.13%
EPS Q2Q%-40.95%
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y-3.51%
Revenue growth 5Y1.94%
Sales Q2Q%-2.48%

3.2 Future

  • BAYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.13% yearly.
  • Based on estimates for the next years, BAYN will show a small growth in Revenue. The Revenue will grow by 2.62% on average per year.
EPS Next Y-10.4%
EPS Next 2Y-1.25%
EPS Next 3Y3.2%
EPS Next 5Y4.13%
Revenue Next Year-0.21%
Revenue Next 2Y1.1%
Revenue Next 3Y1.99%
Revenue Next 5Y2.62%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BAYN.DE Yearly Revenue VS EstimatesBAYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
BAYN.DE Yearly EPS VS EstimatesBAYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. BAYN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 8.37, the valuation of BAYN can be described as reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of BAYN indicates a rather cheap valuation: BAYN is cheaper than 98.04% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of BAYN to the average of the S&P500 Index (27.87), we can say BAYN is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 9.34, the valuation of BAYN can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BAYN indicates a rather cheap valuation: BAYN is cheaper than 92.16% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.51, BAYN is valued rather cheaply.
Industry RankSector Rank
PE 8.37
Fwd PE 9.34
BAYN.DE Price Earnings VS Forward Price EarningsBAYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • BAYN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BAYN is more expensive than 62.75% of the companies in the same industry.
  • BAYN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BAYN is cheaper than 84.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.74
EV/EBITDA 39.87
BAYN.DE Per share dataBAYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.25%
EPS Next 3Y3.2%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BAYN.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.27%, BAYN is not a good candidate for dividend investing.
  • BAYN's Dividend Yield is slightly below the industry average, which is at 1.94.
  • Compared to an average S&P500 Dividend Yield of 1.81, BAYN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.27%

5.2 History

  • The dividend of BAYN decreases each year by -46.01%.
Dividend Growth(5Y)-46.01%
Div Incr Years0
Div Non Decr Years1
BAYN.DE Yearly Dividends per shareBAYN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.51%
EPS Next 2Y-1.25%
EPS Next 3Y3.2%
BAYN.DE Yearly Income VS Free CF VS DividendBAYN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B -10B

More info and screens

Find the best dividend stocksShow peers with best dividend

BAYN.DE Fundamentals: All Metrics, Ratios and Statistics

BAYER AG-REG

FRA:BAYN (4/17/2026, 7:00:00 PM)

41.1

+0.41 (+1.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-04
Earnings (Next)05-12
Inst Owners54.74%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap40.38B
Revenue(TTM)45.58B
Net Income(TTM)-3.62B
Analysts75.86
Price Target45.74 (11.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.27%
Yearly Dividend0.13
Dividend Growth(5Y)-46.01%
DP-3.51%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.61%
Min EPS beat(2)22.06%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)35.24%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.01%
EPS beat(12)9
Avg EPS beat(12)9.7%
EPS beat(16)12
Avg EPS beat(16)8.09%
Revenue beat(2)1
Avg Revenue beat(2)-0.88%
Min Revenue beat(2)-2.42%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-1.34%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)0.67%
Revenue beat(8)3
Avg Revenue beat(8)-1.37%
Revenue beat(12)3
Avg Revenue beat(12)-2.43%
Revenue beat(16)6
Avg Revenue beat(16)-1.51%
PT rev (1m)7.99%
PT rev (3m)33.16%
EPS NQ rev (1m)0.58%
EPS NQ rev (3m)11.13%
EPS NY rev (1m)-6.01%
EPS NY rev (3m)-9.65%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)1.38%
Revenue NY rev (1m)-0.85%
Revenue NY rev (3m)-1.06%
Valuation
Industry RankSector Rank
PE 8.37
Fwd PE 9.34
P/S 0.89
P/FCF 11.74
P/OCF 6.81
P/B 1.56
P/tB N/A
EV/EBITDA 39.87
EPS(TTM)4.91
EY11.95%
EPS(NY)4.4
Fwd EY10.7%
FCF(TTM)3.5
FCFY8.51%
OCF(TTM)6.03
OCFY14.67%
SpS46.39
BVpS26.41
TBVpS-23.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number54.0166 (31.43%)
Profitability
Industry RankSector Rank
ROA -3.46%
ROE -13.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.76%
FCFM 7.54%
ROA(3y)-2.76%
ROA(5y)-0.83%
ROE(3y)-10.29%
ROE(5y)-3.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.1%
ROCE(5y)7.55%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-5.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y1.79%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF 10.93
Debt/EBITDA 18.64
Cap/Depr 89.3%
Cap/Sales 5.46%
Interest Coverage N/A
Cash Conversion 346.9%
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.63
Altman-Z 0.78
F-Score6
WACC6.64%
ROIC/WACCN/A
Cap/Depr(3y)49.46%
Cap/Depr(5y)55.83%
Cap/Sales(3y)5.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.77%
EPS 3Y-14.8%
EPS 5Y-5.13%
EPS Q2Q%-40.95%
EPS Next Y-10.4%
EPS Next 2Y-1.25%
EPS Next 3Y3.2%
EPS Next 5Y4.13%
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y-3.51%
Revenue growth 5Y1.94%
Sales Q2Q%-2.48%
Revenue Next Year-0.21%
Revenue Next 2Y1.1%
Revenue Next 3Y1.99%
Revenue Next 5Y2.62%
EBIT growth 1Y-1416.9%
EBIT growth 3Y-9.26%
EBIT growth 5YN/A
EBIT Next Year51.21%
EBIT Next 3Y20.51%
EBIT Next 5Y10.89%
FCF growth 1Y-25.07%
FCF growth 3Y-6.06%
FCF growth 5Y6.77%
OCF growth 1Y-19.56%
OCF growth 3Y-5.83%
OCF growth 5Y3.89%

BAYER AG-REG / BAYN.DE Fundamental Analysis FAQ

What is the fundamental rating for BAYN stock?

ChartMill assigns a fundamental rating of 2 / 10 to BAYN.DE.


What is the valuation status of BAYER AG-REG (BAYN.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for BAYER AG-REG?

BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.


What is the financial health of BAYER AG-REG (BAYN.DE) stock?

The financial health rating of BAYER AG-REG (BAYN.DE) is 1 / 10.


What is the expected EPS growth for BAYER AG-REG (BAYN.DE) stock?

The Earnings per Share (EPS) of BAYER AG-REG (BAYN.DE) is expected to decline by -10.4% in the next year.